Previous close | 97.71 |
Open | 97.73 |
Bid | 98.94 x 800 |
Ask | 99.68 x 800 |
Day's range | 97.06 - 99.43 |
52-week range | 83.07 - 116.04 |
Volume | |
Avg. volume | 2,103,093 |
Market cap | 24.179B |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 43.92 |
EPS (TTM) | 2.26 |
Earnings date | 13 Aug 2024 - 19 Aug 2024 |
Forward dividend & yield | 2.02 (2.04%) |
Ex-dividend date | 01 Jul 2024 |
1y target est | 113.57 |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. Gross margins improve. However, the rising cost of products is a concern.
Cardinal (CAH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.